Cortechs.ai | Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers
Contact
  • Home
  • /
  • Resources
  • /
  • Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers

Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers

  • Category: Published research

Study to determine the ability of clinically available volumetric MRI (vMRI) and CSF biomarkers, alone or in combination with a quantitative learning measure, to predict conversion to Alzheimer’s disease (AD) in patients with mild cognitive impairment (MCI). 2011 October 12.

[button]Download[/button]

  • Topic: Published research

More Resources

Cortechs.ai | Advancing TBI Evaluation with AI-Driven MRI Analysis: A New Era in Brain Health
  • 2 mins

03/09/2025

Advancing TBI Evaluation with AI-Driven MRI Analysis: A New Era in Brain Health

AI-driven MRI with NeuroQuant® enhances TBI assessment, tracks recovery, and supports better treatment decisions.

Cortechs.ai | Case Study: Leveraging NeuroQuant® for Accurate Diagnosis of Traumatic Brain Injury
  • < 1 mins

03/06/2025

Case Study: Leveraging NeuroQuant® for Accurate Diagnosis of Traumatic Brain Injury

This case highlights the power of advanced neuroimaging tools in delivering precise, evidence-based diagnostics to enhance patient care and clinical decisions.

Cortechs.ai | Traumatic Brain Injury in Athletes: The Role of the NeuroQuant and Automated Volumetric Tracking
  • 3 mins

02/26/2025

Traumatic Brain Injury in Athletes: The Role of the NeuroQuant and Automated Volumetric Tracking

NeuroQuant enables objective brain volume tracking for early TBI detection, recovery monitoring, and safer return-to-play decisions.

Cortechs.ai | Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers
  • 2 mins

02/25/2025

OnQ™ Prostate Solution Enhances Collaboration and Improves MRI for Cancer Detection with RSI Technology

OnQ Prostate enhances MRI tissue characterization, improving sensitivity and specificity in cancer detection, & bridges gaps between radiologists and urologists

Cortechs.ai | Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers
  • 3 mins

02/15/2025

NeuroQuant® Dementia: Advancing Alzheimer’s Disease Care in the Era of DMTs

AI-driven brain volumetric analysis is revolutionizing Alzheimer’s care, providing precise diagnostic support, monitoring, and early detection.

Cortechs.ai | Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers
  • 3 mins

02/09/2025

NeuroQuant® MS:  Advancing Precision in Multiple Sclerosis

Dr. Suzie Bash discusses NeuroQuant MS, noting its ability to segment plaques, analyze volume, and track lesion burden for assessing disease progression

View our insights
Cortechs.ai | Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers
Cortechs.ai | Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers

Empowering precision

and clarity in patient care

5060 Shoreham Place,
Ste 240, San Diego, CA 92122

Cortechs.ai | Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers
  • Solutions
  • © Cortechs.ai 2024
Scroll to Top